glp-1 diarrhea lawsuit in louisiana Wegovy Lawyer GLP-1 drugs more likely to

Discover the top weight loss stocks to buy now

Disclosure: I hold a bullish position in Altimmune (ALT) through call options expiring January 2027 a leveraged, directional position that profits if the stock rises

Scientists don't fully understand the mechanism yet, but people taking GLP-1 drugs tend to eat less ultra-processed food, more fibre, fruit and vegetables, smaller portions, and fewer snacks

Pharma leaders reveal how blockbuster therapies are reshaping M&A priorities and portfolios.

Learn what to expect at 1, 3, 6, and 12 months with expert medical insight.

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats of the blockbuster drugs.